Suivre
Guillaume Bardy
Guillaume Bardy
Médecin, Pharmacien, PhD à Hôpital du Valais
Adresse e-mail validée de hopitalvs.ch
Titre
Citée par
Citée par
Année
Quercetin potentiates insulin secretion and protects INS‐1 pancreatic β‐cells against oxidative damage via the ERK1/2 pathway
E Youl, G Bardy, R Magous, G Cros, F Sejalon, A Virsolvy, S Richard, ...
British journal of pharmacology 161 (4), 799-814, 2010
2922010
Quercetin induces insulin secretion by direct activation of L‐type calcium channels in pancreatic beta cells
G Bardy, A Virsolvy, JF Quignard, MA Ravier, G Bertrand, S Dalle, G Cros, ...
British journal of pharmacology 169 (5), 1102-1113, 2013
1262013
Cafeteria diet induces obesity and insulin resistance associated with oxidative stress but not with inflammation: improvement by dietary supplementation with a melon superoxide …
J Carillon, C Romain, G Bardy, G Fouret, C Feillet-Coudray, S Gaillet, ...
Free Radical Biology and Medicine 65, 254-261, 2013
802013
Is anti-factor Xa chromogenic assay for Rivaroxaban appropriate in clinical practice? Advantages and comparative drawbacks
G Bardy, F Fischer, A Appert, B Baldin, M Stève, A Spreux, T Lavrut, ...
Thrombosis research 136 (2), 396-401, 2015
242015
Thrombosis during thrombopoietin receptor agonist treatment for immune thrombocytopenia. A French multicentric observational study
E Weber, G Moulis, M Mahévas, C Guy, B Lioger, I Durieu, M Hunault, ...
La Revue de Medecine Interne 38 (3), 167-175, 2016
152016
An Unusual Case of Death Probably Triggered by the Association of Buprenorphine at Therapeutic Dose with Ethanol and Benzodiazepines and with Very Low Norbuprenorphine Level
G Bardy, P Cathala, C Eiden, E Baccino, P Petit, O Mathieu
Journal of forensic sciences 60 (s1), S269-S271, 2015
142015
Thromboses sous agonistes du récepteur de la thrombopoïétine au cours du purpura thrombopénique immunologique. Étude rétrospective multicentrique en France
E Weber, G Moulis, M Mahévas, C Guy, B Lioger, I Durieu, M Hunault, ...
La Revue de Médecine Interne 38 (3), 167-175, 2017
52017
Is therapeutic drug monitoring of direct anticoagulants really unnecessary?
B Baldin, M Warembourg, G Bardy, L Startari, F Rocher, A Spreux, ...
Circulation 132 (suppl_3), A11598-A11598, 2015
12015
Despite Modifications of Dabigatran Pharmacokinetics, P-gp Antagonists Do Not Increase Bleeding Occurrence In the elderly
MD DRICI, M Bernier, G Bardy, E Van Obberghen, A Spreux, T Lavrut, ...
Proceedings for Annual Meeting of The Japanese Pharmacological Society …, 2018
2018
Rôles de ERK1/2 et des protéines d’échange directement activées par l’AMPc (Epac) dans le mécanisme de l’effet insulino-sécrétoire d’un polyphénol, la quercétine
C Oiry-Cuq, E Youl, M Bayle, J Neasta, J NGuyen, G Bardy, R Magous, ...
Diabetes & Metabolism 43 (2), A83, 2017
2017
Are patients with a high plasma level of dabigatran more at risk of bleeding?
SL Lancrerot, G Bardy, F Rocher, B Baldin, A Spreux, L Startari, T Lavrut
FUNDAMENTAL & CLINICAL PHARMACOLOGY 30, 59-59, 2016
2016
Is chromogenic anti-factor xa assay and therapeutic drug monitoring for rivaroxaban appropriate in clinical practice?
MD Drici, F Fischer, T Lavrut, L Startari, A Appert, G Bardy, B Baldin
EUROPEAN HEART JOURNAL 36, 143-143, 2015
2015
Is the positive benefit/risk of novel anticoagulants ratio maintained in the elderly patient?
S Caro, S Lancrerot, B Teboul, G Bardy, L Startari, MD Drici
FUNDAMENTAL & CLINICAL PHARMACOLOGY 29, 43-43, 2015
2015
Acute renal failure as a new safety signal from crizotinib
M Steve-Dumont, S Peyrat, F Ajmia, G Bardy, F Rocher, B Baldin, ...
FUNDAMENTAL & CLINICAL PHARMACOLOGY 28, 62-62, 2014
2014
P2120 La quercétine stimule la sécrétion d’insuline par une activation directe des canaux calciques de type L dans les cellules β pancréatiques INS-1
G Bardy, A Virsolvy, E Youl, JF Quignard, G Cros, R Magous, S Richard, ...
Diabetes & Metabolism 39, A96, 2013
2013
Effets insulino-sécrétoires et protecteurs de la quercétine au niveau de la cellule beta pancréatique: implication du calcium intracellulaire et de ERK1/2
G Bardy
Montpellier 1, 2012
2012
Quercetin potentiates insulin secretion in INS-1 pancreatic beta cells through L-type voltage-dependent calcium channels
G Bardy, R Magous, G Cros, S Richard, V Anne, C Oiry
FUNDAMENTAL & CLINICAL PHARMACOLOGY 26, 84-84, 2012
2012
Quercetin potentiates insulin secretion of INS-1 cells by a mechanism involving L-type calcium channels
G Bardy, R Magous, G Cros, S Richard, A Virsolvy, C Oiry
DIABETES & METABOLISM 37, A73-A73, 2011
2011
P165-La quercétine potentialise la sécrétion d’insuline des cellules INS-1 par un mécanisme impliquant les canaux calciques de type L
G Bardy, R Magous, G Cros, S Richard, A Virsolvy, C Oiry
Diabetes & Metabolism 37 (1), A73, 2011
2011
Quercetin potentiates insulin secretion and protects the functionality of INS-1 pancreatic beta-cells against oxidative damage via the ERK1/2 pathway
E Youl, G Bardy, R Magous, G Cros, P Petit, D Bataille, C Oiry
FUNDAMENTAL & CLINICAL PHARMACOLOGY 24, 93-94, 2010
2010
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20